Genetic Basis for Fibrosis in Alström Syndrome
Author Information
Author(s): Zulato Elisabetta, Favaretto Francesca, Veronese Caterina, Campanaro Stefano, Marshall Jan D., Romano Sara, Cabrelle Anna, Collin Gayle B., Zavan Barbara, Belloni Anna S., Rampazzo Enrica, Naggert Jürgen K., Abatangelo Giovanni, Sicolo Nicola, Maffei Pietro, Milan Gabriella, Vettor Roberto
Primary Institution: Department of Medical and Surgical Sciences, University of Padua, Padua, Italy
Hypothesis
The study investigates the role of ALMS1 mutations in the generation and maintenance of pathological fibrosis in Alström Syndrome.
Conclusion
ALMS1-deficient fibroblasts exhibit excessive extracellular matrix production and resistance to apoptosis, contributing to fibrosis.
Supporting Evidence
- ALMS fibroblasts showed a longer cell cycle and were more resistant to apoptosis compared to controls.
- Gene expression analysis revealed up-regulation of genes related to extracellular matrix components and fibrosis.
- ALMS fibroblasts displayed cytoskeleton abnormalities and migration impairment.
Takeaway
The study found that cells from patients with Alström Syndrome make too much of a substance that helps form scars and are harder to kill when they should die.
Methodology
Gene expression analysis, ultrastructural characterization, and functional assays were performed on dermal fibroblast cultures from ALMS patients.
Limitations
The study is limited by the small sample size of only four patients.
Participant Demographics
4 patients (3 males, 1 female) aged 24-37 years with typical clinical features of Alström Syndrome.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website